Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06445608 · ClinicalTrials.gov registry record · NA

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

A NA study of Coronary Artery Disease, sponsored by Kardion.

Recruiting
Registry status
NA
Development phase
310
Enrollment target
18
Study locations

NCT06445608: Recruiting NA study of Coronary Artery Disease, sponsored by Kardion.

NCT06445608 is a NA study of Coronary Artery Disease that is actively recruiting participants, run by Kardion. The registered enrollment target is 310 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (76% lower). The trial reports 18 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06445608, a NA study of Coronary Artery Disease, is actively recruiting participants, sponsored by Kardion.

RECRUITING
Registry status
NA
Development phase
310 participants
Enrollment target
18
Study locations

Study Summary

This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

Primary Outcome

The primary effectiveness endpoint of the clinical investigation is a composite endpoint of major adverse cardiac and cerebrovascular events (MACCE) comprised of all-cause death, myocardial infarction, stroke/TIA, target lesion revascularization, vascular complications, major bleeding, and acute kidney injury.

Conditions Studied

Interventions

  • DEVICE Percutaneous Mechanical Circulatory Support

Study Locations (18)

Arizona

  • Dignity Health - Chandler Regional Medical Center - Chandler
  • HonorHealth Research and Innovation Institute - Scottsdale

New York

  • Mount Sinai - New York
  • St. Francis Hospital - Roslyn

Ohio

  • The Lindner Research Center at The Christ Hospital - Cincinnati
  • Ohio Health Research Institute - Columbus

Arkansas

  • Arkansas Cardiology, P.A. - Little Rock

Colorado

  • North Suburban Medical Center - Thornton

Connecticut

  • Hartford Hospital - Hartford

Florida

  • Ascension St. Vincent's - Jacksonville

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 310 participants
Start Date 2024-09-03
Est. Completion 2025-12
Phase NA
Kardion

1 total trials

What NCT06445608 shows while recruiting

NCT06445608 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous Mechanical Circulatory Support is the first listed.

NCT06445608 lists 18 locations in 15 states (Arizona, New York, Ohio).

Frequently Asked Questions

What is clinical trial NCT06445608 about?

NCT06445608 is a clinical study titled "PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm". This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

What is the current status of trial NCT06445608?

This trial is currently recruiting. It is a NA study. The enrollment target is 310 participants. The study started on 2024-09-03. Estimated completion is 2025-12.

What conditions does trial NCT06445608 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT06445608?

The interventions under investigation include: Percutaneous Mechanical Circulatory Support (DEVICE).

Who is sponsoring clinical trial NCT06445608?

This trial is sponsored by Kardion, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06445608 being conducted?

This trial has 18 study locations across Arizona, Arkansas, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06445608's enrollment target sits among peer trials

310 101st of 219 higher than 119 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03039439 · 310 participants

    Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

  • NCT04178018 · 310 participants · NA

    Transvaginal Ultrasound and Photoacoustic Imaging of Ovary

  • NCT04878094 · 310 participants · Phase 3

    A Study of Intra-operative Imaging in Women With Ovarian Cancer

  • NCT05459233 · 310 participants · NA

    Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06445608, the US trial registry maintained by the National Library of Medicine. NCT06445608 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.